ams OSRAM is shifting to digital photonics, exploring micro-emitter arrays for optical interconnects in AI data centers (low power, high parallelism). Also in next-gen smart glasses. Trimming to profitable segments, expected positive FCF next year. After the painful 2021 merger overhang, the company is restructuring toward high-growth niches in data center optical links and AR/VR. The turnaround is under-appreciated. A speculative turnaround with potential upside from data center optical interconnects and smart glasses, but requires patience for FCF inflection. Merger integration still incomplete; competition from Coherent, Lumentum; smart glass adoption slow; liquidity/volatility.
Cryoport supports 766 clinical trials and 21 commercial therapies with >70% market share in cell/gene therapy cold chain. FDA regulatory moat due to integration into therapy filings. Pivoted to high-margin platform model after offloading courier to DHL. As CGT therapies scale and fertility preservation demand grows (Cryostork), the recurring revenue model becomes a compounding growth story. The stock is still below 2021 hype levels despite fundamentals improving. Cryoport is the infrastructure backbone for a nascent but exploding therapy class, with a regulatory lock-in that competitors cannot easily replicate. Slower-than-expected CGT adoption; regulatory changes; competition from UPS cold chain or in-house logistics.
SAP is the sovereign cloud play for Europe with its S/4HANA migration and new AI assistant Joule. The recurring revenue base is massive and sticky—businesses cannot easily switch ERP systems. As European companies prioritize digital sovereignty and AI integration, SAP’s installed base provides a predictable upgrade cycle. The stock is often overlooked as a “legacy” name despite growing cloud revenue. SAP offers a low-risk, high-moat bet on European enterprise digitalization with AI tailwinds. Competition from Oracle, Salesforce; slow S/4HANA migration pace; currency headwinds.
Sony dominates >50% of the image sensor market and is shipping on-chip AI sensors (IMX735) for robotics/autonomous vehicles. Tesla and Boston Dynamics are key customers. Trading at PE ~15. As physical AI scales, demand for low-latency vision sensors grows geometrically. The music/pictures segments provide a stable cash-flow floor, masking the semiconductor division’s upside. Sony is a hidden AI infrastructure play mispriced as a consumer electronics/entertainment conglomerate. The sensor business could unlock a re-rating as robotics capex ramps. Cyclicality in smartphone sensors; execution risk in edge AI adoption; geopolitical friction with China affecting supply chain.